PEAK6 Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$26.5M	Buy	281,700 +25,800	+10%	+$2.26M	0.11%	162
2018 Q1	$20.7M	Buy	255,900 +97,200	+61%	+$8.34M	0.09%	219
2017 Q4	$14.2M	Buy	158,700 +37,700	+31%	+$3.28M	0.07%	336
2017 Q3	$11.3M	Buy	121,000 +8,800	+8%	+$778K	0.06%	367
2017 Q2	$10.2M	Sell	112,200 -79,300	-41%	-$7.21M	0.06%	367
2017 Q1	$16.8M	Buy	191,500 +98,500	+106%	+$8.76M	0.14%	159
2016 Q4	$7.7M	Sell	93,000 -400	-0.4%	-$34.4K	0.06%	469
2016 Q3	$8.64M	Buy	93,400 +21,100	+29%	+$1.99M	0.06%	413
2016 Q2	$5.63M	Sell	72,300 -21,500	-23%	-$1.83M	0.04%	607
2016 Q1	$7.74M	Buy	93,800 +31,200	+50%	+$2.54M	0.06%	420
2015 Q4	$6.56M	Buy	62,600 +6,100	+11%	+$637K	0.04%	571
2015 Q3	$5.95M	Buy	56,500 +13,700	+32%	+$1.83M	0.03%	762
2015 Q2	$5.85M	Buy	42,800 +24,200	+130%	+$3M	0.03%	736
2015 Q1	$2.32M	Sell	18,600 -17,900	-49%	-$1.9M	0.02%	1163
2014 Q4	$3.3M	Buy	+36,500	New	+$3.04M	0.02%	921
2014 Q3	–	Sell	-100	Closed	-$6K	–	4682
2014 Q2	$6K	Hold	100	–	–	﹤0.01%	4474
2014 Q1	$7K	Sell	100 -9,900	-99%	-$730K	﹤0.01%	4727
2013 Q4	$704K	Sell	10,000 -51,400	-84%	-$3.49M	﹤0.01%	2357
2013 Q3	$2.22M	Buy	61,400 +58,900	+2,356%	+$3.91M	0.02%	1445
2013 Q2	$139	Buy	+2,500	New	+$156K	﹤0.01%	3897